IVRO
vs
S&P 500
IVRO
S&P 500
Over the past 12 months, IVRO has outperformed S&P 500, delivering a return of +17% compared to the S&P 500's +11% growth.
Stocks Performance
IVRO vs S&P 500
Performance Gap
IVRO vs S&P 500
Performance By Year
IVRO vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Invitro International
Glance View
InVitro International engages in the provision of non-animal testing methods. The company is headquartered in Placentia, California. The firm produces and sells in vitro assay kits to detect, rank and predict the level of irritancy, toxicity or corrosivity of substances on human eye (ocular) and/or skin tissue (dermal). The firm has three vitro products: Ocular Irritection used to evaluate the potential for ocular irritation; Irritection Dermal used to evaluate the potential for dermal irritation, and Corrositex used to determine corrosivity level classifications within regulatory guidelines that are applicable to the transport and storage of chemicals, formulations and hazardous waste. The firm sells its products directly to customers, independent partner laboratories and agents in the United States, Europe, Latin America and Asia. The firm also conducts laboratory testing for those customers who prefer not to conduct their own tests.
